SCHEMBL32665396

SCHEMBL32665396

O=C1C=CC(=O)N1CC1CCN(c2ccc(OS(=O)(=O)F)cc2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 3/20 0.35
CCR3 P51677 3/20 0.35
KCNH2 Q12809 3/20 0.35
CHRM4 P08173 2/20 0.35
TPSAB1 Q15661 1/20 0.35
LMNA P02545 2/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 3/20 0.34
GAA P10253 2/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 2/20 0.33
HSP90AA1 P07900 1/20 0.33
CCR6 P51684 1/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665632 0.88 CHRM4 (0.36) CHRM4ALDH1A1GAATDP1KDM4E
SCHEMBL32665195 0.87 HRH1 (0.37) HRH1CCR3KCNH2CHRM4TPSAB1
SCHEMBL32665143 0.81 L3MBTL3 (0.37) LMNATSHRSMN1; SMN2ALDH1A1GAA
SCHEMBL32665356 0.76 DRD2 (0.34) LMNAALDH1A1GAAHPGDKMT2A
SCHEMBL32665021 0.75 HTR1A (0.38) CHRM4SMN1; SMN2
SCHEMBL32665512 0.74 NR1H2 (0.39) CHRM4LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL32665103 0.72 ALDH1A1 (0.33) LMNAALDH1A1GAAHPGDKMT2A
SCHEMBL32665623 0.71 GSK3A (0.35) CCR3TSHRSMN1; SMN2ALDH1A1KMT2A
SCHEMBL32665268 0.71 CYP2C9 (0.33) LMNATSHRSMN1; SMN2ALDH1A1TDP1
SCHEMBL32665550 0.69 MGLL (0.60) KMT2ACA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A HRH1 3502/4885CCR3 1538/4885KCNH2 4668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.